Kathy Bohannon has been named principal strategist, Pediatrics, at INC Research. She is responsible for developing the operational strategy and providing expertise in the design and execution of pediatric studies.

“Kathy is enhancing our unique team model that leverages our deep therapeutic and regulatory expertise to develop a more holistic approach to pediatric trials,” said John Potthoff, INC’s chief operating officer. “Throughout her impressive career, Kathy has developed and managed pediatric trials across multiple therapeutic areas, clinical settings and pediatric age groups. She will be an invaluable addition to our leadership team as we raise our pediatrics services to a new level.”

Ms. Bohannon comes to INC Research from Premier Research Group where she was the senior director, Clinical Trial Management. In that role, she was project administrator responsible for all contractual, regulatory and project management activities within the Best Pharmaceuticals for Children Act – Coordinating Center (BPCA-CC). Her pediatric experience also includes protocol and program development in compliance with FDA PREA, BPCA legislation, and the European Paediatric Regulation, with recent experience in support of pediatric acute and chronic pain.